Holzer Karen, Brukner Peter, Douglass Jo
Centre for Sports Medicine Research and Education, Faculty of Medicine, Dentistry & Health Sciences, University of Melbourne, Victoria 3010, Australia.
Curr Sports Med Rep. 2002 Apr;1(2):86-92. doi: 10.1249/00149619-200204000-00005.
Exercise-induced asthma (EIA) is a common, yet often unrecognized condition occurring in both known asthmatics and otherwise healthy individuals. Misdiagnosis, both over- and underdiagnosis, is not uncommon. In order to accurately diagnose EIA, a bronchoprovocation challenge test must be performed; the current recommended test is a eucapnic hyperventilation (EVH) challenge test. Although there are a number of treatment options available, both pharmacologic and nonpharmacologic, in most cases medications are required. A range of medications are currently available to either treat or prevent EIA. It is important that the medications used are individualized to the patients needs and monitored to ensure efficacy.
运动诱发性哮喘(EIA)是一种常见但常未被识别的病症,在已知哮喘患者和其他方面健康的个体中均可发生。误诊,包括过度诊断和诊断不足,并不罕见。为了准确诊断EIA,必须进行支气管激发试验;目前推荐的试验是等二氧化碳过度通气(EVH)激发试验。尽管有多种治疗选择,包括药物和非药物治疗,但在大多数情况下都需要药物治疗。目前有一系列药物可用于治疗或预防EIA。重要的是,所使用的药物要根据患者的需求进行个体化,并进行监测以确保疗效。